The stock trades at fair valuations of 18x earnings and 3.4x sales. Despite the general market weakness, the pharmaceutical company stocks are close to all time highs. Alembic pharma's stock price could see decent upside in the coming months.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
